If so, it might not just be regular fatigue, it could be Idiopathic Hypersomnia (IH). This neurological sleep disorder causes overwhelming daytime drowsiness, making it difficult to stay awake and ...

“I found myself prioritizing all my free time as napping opportunities.” Haley Wall shares her diagnosis journey and how she manages life with a sleep disorder that has no cause.

These quiz questions about idiopathic hypersomnia (IH) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.

Irish biopharmaceutical company Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic hypersomnia (IH). The double-blind, ...

Idiopathic Hypersomnia (IH) is a rare and chronic neurological disease that is characterized by excessive daytime sleepiness (EDS) despite sufficient or even long sleep time. EDS in IH cannot be ...

Secondary endpoints of the Vibrance-3 study are changes in the Idiopathic Hypersomnia Severity Scale score and incidence of adverse events. Year to date, shares of Alkermes have gained 13.1% compa ...

Alkermes plc ALKS announced that it has initiated the phase II Vibrance-3 study, evaluating the novel, investigational and oral orexin 2 receptor agonist, ALKS 2680, in adults with idiopathic ...

Secondary endpoints include change in Idiopathic Hypersomnia Severity Scale (IHSS) score and incidence of adverse events. The study is expected to enroll approximately 96 patients with IH across ...

There remains high unmet need for the idiopathic hypersomnia community, as evidenced by a recent survey conducted by the Sleep Consortium 1 in which more than 90% of patients surveyed indicated ...